⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Vitrolife Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Vitrolife Group
↗Gothenburg, Sweden
Vitrolife Group is a global leader in the reproductive health and IVF (in vitro fertilization) market. The company develops, manufactures, and markets medical devices, genetic testing services, and advanced software solutions, including time-lapse incubators and embryo evaluation systems, to support fertility clinics and patients worldwide.
Headquartered in Sweden, the company operates across EMEA, the Americas, and APAC. It is known for its focus on innovation in embryo culture, selection, and genetic analysis, aiming to improve the success rates of fertility treatments through both hardware and AI-driven digital health tools.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Reproductive Health / IVF
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$300M-$400M
Founded:1994
Ownership:public
Status:operating
STOCK
Exchange:NASDAQ Stockholm
Ticker:VITR
Market Cap:$1.3B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Medical Devices, Genetic Testing, Digital Health/AI
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Juno Genetics, eFertility
Key Partnerships:Various IVF clinics and academic research institutions globally for clinical validation of AI and time-lapse technologies.
COMPETITION
Position:Leader
Competitors:CooperSurgical, Hamilton Thorne, Cook Medical, Esco Medical, Merck KGaA
LINKS
Website:vitrolife.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Vitrolife Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.